The relationship between osteoporosis treatment history and receipt of a second zoledronic acid dose
Konstantelos N, Kim S, Cheung AM, Burden AM, Grootendorst P, Cadarette SM. Osteoporos Int. 2025 Sep 4 [Epub ahead of print].
Objectives — To determine whether the minimum legal age (MLA) for cannabis purchases is associated with reductions in cannabis-related hospitalizations in youths.
Methods — We performed a population-based study examining all hospitalizations for cannabis use in Canada for individuals aged 15 to 44 years (n = 14.6 million in 2018) between January 1, 2015, and March 31, 2022. MLAs varied across Canada. We used a controlled interrupted time series design to compare changes in cannabis-related hospitalizations between individuals above and below the MLA.
Results — There were 137 901 cannabis-related hospitalizations during the study. Prelegalization rates of hospitalizations were increasing by 2% per quarter for individuals above and below the MLA. After legalization, hospitalizations began declining by 2% per quarter in individuals below the MLA (rate ratio [RR] quarterly slope change = 0.96; 95% confidence interval [CI] = 0.95, 0.98) with no slope change for individuals above the MLA. The total effect, 3.5 years after legalization, was a 34% reduction (relative difference = 0.66; 95% CI = 0.49, 0.91; P = .011) in hospitalizations for those below relative to those above the MLA.
Conclusions — Nonmedical cannabis legalization in Canada was associated with reductions in cannabis-related hospitalizations for youths below the MLA and with ongoing increases for individuals above the MLA.
Myran DT, Talarico R, Pacula RL, Xiao J, Manuel D, Hobin E, Konikoff L, Tanuseputro P, Taljaard M. Am J Public Health. 2025; May 22 [Epub ahead of print].
The ICES website uses cookies. If that’s okay with you, keep on browsing, or learn more about our Privacy Policy.